These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 33821857)

  • 21. Effect of Topical Intranasal Therapy on Epistaxis Frequency in Patients With Hereditary Hemorrhagic Telangiectasia: A Randomized Clinical Trial.
    Whitehead KJ; Sautter NB; McWilliams JP; Chakinala MM; Merlo CA; Johnson MH; James M; Everett EM; Clancy MS; Faughnan ME; Oh SP; Olitsky SE; Pyeritz RE; Gossage JR
    JAMA; 2016 Sep; 316(9):943-51. PubMed ID: 27599329
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Prospective randomized trial of sclerotherapy vs standard treatment for epistaxis due to hereditary hemorrhagic telangiectasia.
    Boyer H; Fernandes P; Le C; Yueh B
    Int Forum Allergy Rhinol; 2015 May; 5(5):435-40. PubMed ID: 25643928
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Epidemiological, clinical and endoscopic features of epistaxis severity and quality of life in Hereditary haemorrhagic telangiectasia: a cross-sectional study.
    Pagella F; Maiorano E; Ugolini S; Lizzio R; Sovardi F; Mirabella R; Nanfito L; Tinelli C; De Silvestri A; Olivieri C; Spinozzi G; Matti E
    Rhinology; 2021 Dec; 59(6):577-584. PubMed ID: 34726201
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Classification of endonasal HHT lesions using digital microscopy.
    Haubner F; Schneider A; Schinke H; Bertlich M; Weiss BG; Canis M; Kashani F
    Orphanet J Rare Dis; 2021 Apr; 16(1):182. PubMed ID: 33865423
    [TBL] [Abstract][Full Text] [Related]  

  • 25. An epistaxis severity score for hereditary hemorrhagic telangiectasia.
    Hoag JB; Terry P; Mitchell S; Reh D; Merlo CA
    Laryngoscope; 2010 Apr; 120(4):838-43. PubMed ID: 20087969
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Correlation of severity of epistaxis with nasal telangiectasias in hereditary hemorrhagic telangiectasia (HHT) patients.
    Pagella F; Colombo A; Matti E; Giourgos G; Tinelli C; Olivieri C; Danesino C
    Am J Rhinol Allergy; 2009; 23(1):52-8. PubMed ID: 19379613
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Epistaxis in hereditary haemorrhagic telangiectasia.
    Haitjema T; Balder W; Disch FJ; Westermann CJ
    Rhinology; 1996 Sep; 34(3):176-8. PubMed ID: 8938889
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Sclerotherapy and Topical Nasal Propranolol: An Effective and Safe Therapy for HHT-Epistaxis.
    Esteban-Casado S; Martín de Rosales Cabrera AM; Usarralde Pérez A; Martínez Simón JJ; Zhan Zhou E; Marcos Salazar MS; Pérez Encinas M; Botella Cubells L
    Laryngoscope; 2019 Oct; 129(10):2216-2223. PubMed ID: 30908653
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Evidence-based management of epistaxis in hereditary haemorrhagic telangiectasia.
    Syed I; Sunkaraneni VS
    J Laryngol Otol; 2015 May; 129(5):410-5. PubMed ID: 25736077
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Quality of life in patients with hereditary haemorrhagic telangiectasia (HHT).
    Zarrabeitia R; Fariñas-Álvarez C; Santibáñez M; Señaris B; Fontalba A; Botella LM; Parra JA
    Health Qual Life Outcomes; 2017 Jan; 15(1):19. PubMed ID: 28114930
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Coblation for epistaxis management in patients with hereditary haemorrhagic telangiectasia: a multicentre case series.
    Joshi H; Woodworth BA; Carney AS
    J Laryngol Otol; 2011 Nov; 125(11):1176-80. PubMed ID: 21846415
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Efficacy of a topical sesame/rose geranium oil compound in patients with hereditary hemorrhagic telangiectasia associated epistaxis.
    Reh DD; Hur K; Merlo CA
    Laryngoscope; 2013 Apr; 123(4):820-2. PubMed ID: 23401038
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The natural history of epistaxis in patients with hereditary hemorrhagic telangiectasia in the Norwegian population: a cross-sectional study.
    Dheyauldeen S; Abdelnoor M; Bachmann-Harildstad G
    Am J Rhinol Allergy; 2011; 25(4):214-8. PubMed ID: 21819756
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Injection of bevacizumab and cyanoacrylate glue for hereditary hemorrhagic telangiectasia.
    Khoueir N; Borsik M; Camous D; Herman P; Verillaud B
    Laryngoscope; 2019 Oct; 129(10):2210-2215. PubMed ID: 31566760
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Vitamin D levels are associated with epistaxis severity and bleeding duration in hereditary hemorrhagic telangiectasia.
    Weber LM; McDonald J; Whitehead K
    Biomark Med; 2018 Apr; 12(4):365-371. PubMed ID: 29537299
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Efficacy and safety of thalidomide for the treatment of severe recurrent epistaxis in hereditary haemorrhagic telangiectasia: results of a non-randomised, single-centre, phase 2 study.
    Invernizzi R; Quaglia F; Klersy C; Pagella F; Ornati F; Chu F; Matti E; Spinozzi G; Plumitallo S; Grignani P; Olivieri C; Bastia R; Bellistri F; Danesino C; Benazzo M; Balduini CL
    Lancet Haematol; 2015 Nov; 2(11):e465-73. PubMed ID: 26686256
    [TBL] [Abstract][Full Text] [Related]  

  • 37. In-Office KTP Laser for Treating Hereditary Hemorrhagic Telangiectasia-Associated Epistaxis.
    Wu V; Kell E; Faughnan ME; Lee JM
    Laryngoscope; 2021 Mar; 131(3):E689-E693. PubMed ID: 32557619
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Nasal closure for the treatment of epistaxis secondary to hereditary hemorrhagic telangiectasia.
    Sena Esteves S; Cardoso C; Silva A; Abrunhosa J; Almeida E Sousa C
    Acta Otorrinolaringol Esp; 2016; 67(6):345-348. PubMed ID: 27079134
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Topical application of timolol decreases the severity and frequency of epistaxis in patients who have previously undergone nasal dermoplasty for hereditary hemorrhagic telangiectasia.
    Ichimura K; Kikuchi H; Imayoshi S; Dias MS
    Auris Nasus Larynx; 2016 Aug; 43(4):429-32. PubMed ID: 26739947
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Intranasal bevacizumab treatment on epistaxis in hereditary haemorrhagic telangiectasia: a case report.
    García-Martín E; Pernía-López S; Martínez-Ortega PA; Monje B; Ruiz-Martínez C; Sanjurjo-Saez M
    Eur J Hosp Pharm; 2019 Jul; 26(4):226-228. PubMed ID: 31338174
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.